Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication
- PMID: 38578122
- DOI: 10.1111/jvh.13928
Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication
Abstract
The current World Health Organization (WHO) Hepatitis Elimination Strategy suffers from lack of a target for diagnosing or expunging occult HBV infection. A sizable segment of the global population has an undetected HBV infection, particularly the high-risk populations and those residing in countries like India with intermediate endemicity. There is growing proof that people with hidden HBV infection can infect others, and that these infections are linked to serious chronic hepatic complications, especially hepatocellular carcinoma. Given the current diagnostic infrastructure in low-resource settings, the WHO 2030 objective of obliterating hepatitis B appears to be undeniably challenging to accomplish. Given the molecular basis of occult HBV infection strongly linked to intrahepatic persistence, patients may inexplicably harbour HBV genomes for a prolonged duration without displaying any pronounced clinical or biochemical signs of liver disease, and present histological signs of moderate degree necro-inflammation, diffuse fibrosis, and hence the international strategy to eradicate viral hepatitis warrants inclusion of occult HBV infection.
Keywords: HBV cure; HBV in India; HBsAg negative; cccDNA; occult HBV; viral hepatitis eradication.
© 2024 John Wiley & Sons Ltd.
References
REFERENCES
-
- Saitta C, Pollicino T, Raimondo G. Occult hepatitis B virus infection: an update. Viruses. 2022;14:1504. doi:10.3390/v14071504
-
- Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS. Taormina workshop on occult HBV infection faculty members: update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71:397‐408.
-
- Kao J‐H, Chen D‐S. Hepatitis B Virus and Liver Disease. Springer; 2018.
-
- Wang C, Xue R, Wang X, Xiao L, Xian J. High‐sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable. Front Cell Infect Microbiol. 2023;13:1186877.
-
- Sarin SK, Kumar M, Lau GK, et al. Asian‐Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1‐98.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical